|
Market Closed -
Nasdaq
16:00:00 2026-08-24 EDT
|
5-day change | 1st Jan Change | ||
| 4.100 USD | +2.50% |
|
-3.30% | +114.66% |
| 08-11 | C4 Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 06-29 | C4 Therapeutics, Inc.(NasdaqGS:CCCC) added to Russell 2000 Index | CI |
Chart: Technical Analysis
Stock exchange
Nasdaq
CCCC 4.100 $
+2.50%
7.18M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| CCCC | 4.100USD | +2.50% | 7.18M $ | |
CBOE
| CCCC | 4.110USD | +2.70% | 337K $ |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 4.265 | 4.67 | 4.37 |
| Spread/Res. | -3.87% | -12.21% | -6.18% |
| Spread/Supp. | +7.05% | +22.02% | +42.36% |
| Support | 3.83 | 3.36 | 2.88 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- CCCC Stock
- Charts C4 Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
